IQVIA™ Real-World Insights Bibliography

Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Author(s): Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations(s): 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publication(s):  ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Type(s): Oral presentation,
Countries: Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES
Author(s): M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group
Affiliations(s): 1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway
Publication(s):  EULAR, Madrid, 2017
Document Type(s): Abstract,
Countries: Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland,
Click here for the abstract
C:
Y:
Rheumatology,
2017
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publication(s):  Clinical Epidemiology
Document Type(s): Article,
Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK,
Click here for the abstract
C:
Y:
Oncology,
2016
  L:
A:
English
Literature Review,
  Add to report
 
 
Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe.
Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3
Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium
Publication(s):  19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Type(s): Abstract,
Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK,
C:
Y:
Cardiovascular disease,
2016
  L:
A:
English
  Add to report
 
 
Survey on appropriateness of use of nimesulide in nine European countries
Author(s): Franchi S1, Heiman F2, Visentin E2, Sacerdote P1.
Affiliations(s): 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 2Cegedim Strategic Data Medical Research Srl, Milan, Italy.
Publication(s):  Drug, Healthcare and Patient Safety 2015:7 51-55
Document Type(s): Article,
Countries: Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia,
C:
Y:
Pain,
2015
  L:
A:
English
Survey research,
  Add to report
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Czech Republic
Author(s): Troelsgaard A1, Pitcher A2, Veselá Š3, Lovato E2, Hemels M1
Affiliations(s): Janssen A/S, Birkerød, Denmark, 2IMS Health, London, UK, 3Janssen-Cilag Czech Republic, Prague, Czech Republic
Publication(s):  ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Type(s): Poster,
Countries: Czech,
C:
Y:
Diabetes,
2014
  L:
A:
English
Economic evaluation,
  Add to report
 
 
Long-term clinical and cost outcomes of treatment with insulin detemir plus insulin aspart in type 1 diabetes patients in the Czech setting; data from the predictive study
Author(s): 1Clegg JP, 1Valentine WJ, 2Rychna K, 3Honka M, 4Dole?al T
Affiliations(s): 1IMS, Allschwil, Switzerland, 2Novo Nordisk s.r.o, Praha 6, Czech Republic, 3Faculty Hospital Ostrava, Ostrava, Czech Republic, 4Charles University in Prague, Prague 10, Czech Republic
Publication(s):  ISPOR 2008 13th Annual International Congress
Document Type(s): Poster,
Countries: Czech,
C:
Y:
Diabetes,
2008
  L:
A:
English
Cost effectiveness,
  Add to report